Catatonia

USMLE Step 1 trap: Incorrectly anchors catatonia to schizophrenia rather than recognizing mood disorders as the most common psychiatric cause. Catatonia is most commonly associated with mood disorders (especially bipolar disorder with psychotic features) and can also occur in medical conditions, NMS, and autism spectrum disorder.

Catatonia is a neuropsychiatric syndrome characterized by abnormalities in movement, behavior, and responsiveness — think mutism, posturing, waxy flexibility, stupor, echolalia, and echopraxia — and USMLE Step 1 tests it through a counterintuitive management trap: students reach for antipsychotics when benzodiazepines are actually correct. It's not a diagnosis itself but a syndrome that sits on top of another disorder. Step 1 tests whether you can recognize the clinical picture, identify the correct workup, and choose the right treatment — and all three angles are live traps. The features are distinctive enough that recognition should be automatic if you know them cold.

The exam loves to test catatonia in context: a patient who is mute and holding a bizarre posture gets presented in a vignette, and you're asked what to do next or what the underlying cause is. The trap is anchoring — students see 'psychotic-looking patient' and reach for antipsychotics or assume schizophrenia. That's wrong on both counts. USMLE Step 1 specifically tests whether you know that mood disorders (especially bipolar disorder with psychotic features) are the most common psychiatric cause, not schizophrenia.

What makes catatonia tricky is that it looks like several other things at once: a psychotic break, an obtunded medical patient, or even NMS (which itself can look like catatonia). Management is counterintuitive — the treatment is benzodiazepines, and antipsychotics are relatively contraindicated. The lorazepam challenge is a high-yield concept because it's simultaneously diagnostic and the start of treatment, which is a two-for-one concept the exam loves to probe.

From real student decks

3%have cards covering this topic

0%have mature cards

A gap in most decks — fewer than half of students in our cohort have cards covering this topic.

Common misconceptions

Common mistake

Wrong: Catatonia is a feature exclusive to schizophrenia.

Right: Catatonia is most commonly associated with mood disorders (especially bipolar disorder with psychotic features) and can also occur in medical conditions, NMS, and autism spectrum disorder.

Catatonia can appear in schizophrenia, but the most common psychiatric cause is actually a mood disorder — particularly bipolar disorder with psychotic features or severe major depression. Medical conditions, NMS, and autism spectrum disorder are also recognized causes. When you see catatonia on USMLE Step 1, don't default to 'schizophrenia'; look at the full clinical picture for affective symptoms or a medical trigger.

Common mistake

Wrong: The lorazepam challenge is only a diagnostic test and that a positive response does not guide treatment.

Right: The lorazepam challenge is both diagnostic (transient improvement confirms catatonia) and therapeutic (benzodiazepines are first-line treatment for catatonia).

The lorazepam challenge isn't just a diagnostic test you run and then decide what to do — it's a single intervention that does double duty. A positive response (transient improvement in catatonic features) confirms the syndrome, and continued benzodiazepine therapy is the treatment. Think of it as: you give lorazepam, it works, so you keep giving lorazepam. Diagnosis and first-line therapy are the same action.

Common mistake

Wrong: Antipsychotics should be given first for catatonia because it looks like a psychotic state.

Right: Antipsychotics are relatively contraindicated in catatonia because they can worsen the syndrome and precipitate neuroleptic malignant syndrome; benzodiazepines and ECT are first-line.

Catatonia looks like a psychotic state, so the reflex to reach for antipsychotics is understandable — but it's dangerous. Antipsychotics lower the dopamine tone that catatonia is already dysregulating and can precipitate neuroleptic malignant syndrome, which is itself a life-threatening catatonia-like syndrome. Benzodiazepines and ECT are first-line; antipsychotics should be avoided until catatonia has resolved.

Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →

Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

Recognize the classic features of catatonia: mutism, rigid posturing, waxy flexibility (catalepsy), stupor, echolalia (repeating words), and echopraxia (mimicking movements).
Know that the lorazepam challenge — giving IV or IM lorazepam and watching for transient improvement — both confirms the diagnosis of catatonia and initiates first-line treatment simultaneously.
Select the correct management: benzodiazepines are first-line, ECT is used for refractory or severe cases, and the underlying disorder (mood disorder, medical condition, etc.) must also be treated.

Can you avoid these mistakes?

A 28-year-old woman with a history of bipolar disorder is brought in mute, holding her arm in a raised position for 20 minutes, and will repeat back whatever the examiner says. What is the next best step in management?

A medical student argues that catatonia is a subtype of schizophrenia. What is the most accurate correction, and what is the most common psychiatric cause of catatonia?

You give a catatonic patient 2 mg of IV lorazepam and he becomes transiently more responsive and mobile. What does this response tell you about diagnosis, and what does it tell you about next steps in treatment?

A psychiatry resident wants to start haloperidol in a catatonic patient because 'it looks psychotic.' Why is this potentially harmful, and what syndrome could it precipitate?

Catatonia

Common misconceptions

What the exam tests

Can you avoid these mistakes?

Related topics